Search results
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 6 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 6 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital...
Digital Journal· 6 days agoCapital One 1st Annual Biotech/Biopharma Disruptors Event - May 14, 2024 Panel: New Potential Dermatology Treatments for Psoriasis, Urticaria, & Alopecia ...
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 3 days agoStockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock. Can-Fite ...
Want Tighter, Firmer Skin Over 40? Doctors Recommend These 3 Hydrating Serums For A Supple...
SheFinds via Yahoo News· 4 days agoEnhancing your skincare regimen with a serum is a smart move that can provide impressive results....
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoSTRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the
The hell of drug pricing boards
Maryland Matters via Yahoo News· 5 days agoJames K. Glassman, the well-known economist whose clients have included pharmaceutical companies, makes the case against prescription drug affordability boards. The post The hell of drug pricing boards appeared first on Maryland Matters.
Journey Medical Corp Announces New Journey with the Experts Video Featuring Karan Lal, DO
Digital Journal· 3 days agoDr. Lal sits down with Journey Medical to discuss keloids, including what they are, why they occur, and how those affected can seek treatment from their local dermatology ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European...
Benzinga· 23 hours agoPositive trajectory with Net Sales increase by 6.6% to a total of €247.4 MM, EBITDA increase of 1.4% YoY to a total of €52.5 MM driven by higher overall sales Performance driven by biologics as key growth engines,
